An overview of new biomolecular pathways in pathogen-related cancers

References

• Warburg O , WindF, NegeleinE. The metabolism of tumors in the body. J. Gen. Physiol.8(6), 519–530 (1927).
   PubMedGoogle Scholar
• Lindau Nobel Laureate Meetings org . Otto Warburg Lecture – On the Primary Causes and on the Secondary Causes of Cancer. www.mediatheque.lindau-nobel.org
   Google Scholar
• Kim JW , DangCV. Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res.66(18), 8927–8930 (2006).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA. The hallmarks of cancer. Cell100(1), 57–70 (2000).
   PubMed Web of Science ®Google Scholar
• Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Tayer W . Appendix I. In: Celsus Cornelius A. De Medicina. Latin Transcription by F. Marx, Teubner edition1915; English translation by W. G. Spencer, Loeb edition 1938. Loeb Classical Library edition, 1935 (2002). http://penelope.uchicago.edu
   Google Scholar
• Hippocrates of Cos . Book VI, 38. In: Aphorisms (Greek and Latin bilingual edition). FoesA ( Eds.). Bibliothèque numérique Medic@: MS 595 – BIUM 2. bibliothèques interuniversitaires de médecine (BIUM), Paris, published apud Andreae Wecheli heredes, Claudium Marnium et Joannem Aubrium, Francofurti, (1595). www2.biusante.parisdescartes.fr
   Google Scholar
• Hajdu SI . A note from history: landmarks in history of cancer, part 1. Cancer117(5), 1097–1102 (2011).
   PubMed Web of Science ®Google Scholar
• Celsus Cornelius A . Book V 28, 2A-C. In: De Medicina. Latin Transcription by F. Marx, Teubner edition1915; English translation by W. G. Spencer, Loeb edition 1938. Loeb Classical Library edition, 1935, (2002). http://penelope.uchicago.edu
   Google Scholar
• Galenus Claudius of Pergamon . De Methodo Medendi, Liber XIV. In: Claudii Galeni Opera Omnia (Vol. X). KühnKG ( Ed.). Car. Cnoblochii, Leipzig, 945–1026 (1825). www2.biusante.parisdescartes.fr.
   Google Scholar
• Galenus Claudius of Pergamon . De Tumoribus praeter naturam, Cap. XII. In: Claudii Galeni Opera Omnia (Vol. VII). KühnKG ( Ed.). Car. Cnoblochii, Leipzig, 705–732 (1824). www2.biusante.parisdescartes.fr.
   Google Scholar
• Adriani Ravesteini . Lexicon Medicum Graeco-Latinum a Batholomeo Castello Messanense inchoatum. Art. Med. Doct. ex Hippocr. Galen. Avicenn. atque aliorum celeberrimorum Medicorum Monumnetis. Arnoldum Leers, Roterodami (1665). https://books.google.it.
   Google Scholar
• TCGA . Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature455(7216), 1061–1068 (2008).
   PubMed Web of Science ®Google Scholar
• TCGA . Integrated genomic analyses of ovarian carcinoma. Nature474(7353), 609–615 (2011).
   PubMed Web of Science ®Google Scholar
• TCGA . Comprehensive molecular characterization of gastric adenocarcinoma. Nature513(7517), 202–209 (2014).
   PubMed Web of Science ®Google Scholar
• TCGA . Comprehensive genomic characterization of squamous cell lung cancers. Nature489(7417), 519–525 (2012).
   PubMed Web of Science ®Google Scholar
• TCGA . Comprehensive molecular characterization of urothelial bladder carcinoma. Nature507(7492), 315–322 (2014).
   PubMed Web of Science ®Google Scholar
• TCGA . Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature499(7456), 43–49 (2013).
   PubMedGoogle Scholar
• TCGA . Comprehensive molecular characterization of human colon and rectal cancer. Nature487(7407), 330–337 (2012).
   PubMed Web of Science ®Google Scholar
• TCGA . Comprehensive molecular portraits of human breast tumours. Nature490(7418), 61–70 (2012).
   PubMed Web of Science ®Google Scholar
• Martinez E , YoshiharaK, KimH, MillsGM, TrevinoV, VerhaakRG. Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects. Oncogene doi:10.1038/onc.2014.216 (2014) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Verhaak RG , HoadleyKA, PurdomEet al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell17(1), 98–110 (2010).
   PubMed Web of Science ®Google Scholar
• Hu X , SternHM, GeLet al. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol. Cancer Res.7(4), 511–522 (2009).
   PubMed Web of Science ®Google Scholar
• Turner NC , Reis-FilhoJS. Basal-like breast cancer and the BRCA1 phenotype. Oncogene25(43), 5846–5853 (2006).
   PubMed Web of Science ®Google Scholar
• Foulkes WD , StefanssonIM, ChappuisPOet al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J. Natl Cancer Inst.95(19), 1482–1485 (2003).
   PubMedGoogle Scholar
• Hernando E , NahleZ, JuanGet al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature430(7001), 797–802 (2004).
   PubMed Web of Science ®Google Scholar
• Puc J , KeniryM, LiHSet al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell7(2), 193–204 (2005).
   PubMed Web of Science ®Google Scholar
• Shen WH , BalajeeAS, WangJet al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell128(1), 157–170 (2007).
   PubMed Web of Science ®Google Scholar
• Rouzier R , PerouCM, SymmansWFet al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res.11(16), 5678–5685 (2005).
   PubMed Web of Science ®Google Scholar
• Bosco EE , WangY, XuHet al. The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J. Clin. Invest.117(1), 218–228 (2007).
   PubMed Web of Science ®Google Scholar
• McCabe N , TurnerNC, LordCJet al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res.66(16), 8109–8115 (2006).
   PubMed Web of Science ®Google Scholar
• Takahashi K , YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4), 663–676 (2006).
   PubMed Web of Science ®Google Scholar
• Chiou SH , WangML, ChouYTet al. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial–mesenchymal transdifferentiation. Cancer Res.70(24), 10433–10444 (2010).
   PubMed Web of Science ®Google Scholar
• Lopez-Bertoni H , LalB, LiAet al. DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2. Oncogene doi:10.1038/onc.2014.334 (2014) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Cao L , ZhouY, ZhaiBet al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol.11, 71 (2011).
   PubMed Web of Science ®Google Scholar
• Bareiss PM , PaczullaA, WangHet al. SOX2 expression associates with stem cell state in human ovarian carcinoma. Cancer Res.73(17), 5544–5555 (2013).
   PubMed Web of Science ®Google Scholar
• Ma L , LaiD, LiuT, ChengW, GuoL. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim. Biophys. Sin.(Shanghai)42(9), 593–602 (2010).
   PubMed Web of Science ®Google Scholar
• Goldie SJ , MulderKW, TanDW, LyonsSK, SimsAH, WattFM. FRMD4A upregulation in human squamous cell carcinoma promotes tumor growth and metastasis and is associated with poor prognosis. Cancer Res.72(13), 3424–3436 (2012).
   PubMed Web of Science ®Google Scholar
• Passegue E , JamiesonCH, AillesLE, WeissmanIL. Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics?Proc. Natl Acad. Sci. USA100(Suppl. 1), 11842–11849 (2003).
   PubMedGoogle Scholar
• Mani SA , GuoW, LiaoMJet al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell133(4), 704–715 (2008).
   PubMed Web of Science ®Google Scholar
• Biddle A , LiangX, GammonLet al. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res.71(15), 5317–5326 (2011).
   PubMed Web of Science ®Google Scholar
• Levine AJ . The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Virology384(2), 285–293 (2009).
   PubMed Web of Science ®Google Scholar
• Yim EK , ParkJS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res. Treat.37(6), 319–324 (2005).
   PubMedGoogle Scholar
• Feng H , ShudaM, ChangY, MoorePS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science319(5866), 1096–1100 (2008).
   PubMed Web of Science ®Google Scholar
• Peng R , GordadzeAV, Fuentes PananaEMet al. Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses. J. Virol.74(1), 379–389 (2000).
   PubMed Web of Science ®Google Scholar
• Waltzer L , PerricaudetM, SergeantA, ManetE. Epstein–Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J. Virol.70(9), 5909–5915 (1996).
   PubMed Web of Science ®Google Scholar
• Subramanian C , HasanS, RoweM, HottigerM, OrreR, RobertsonES. Epstein–Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation. J. Virol.76(10), 4699–4708 (2002).
   PubMed Web of Science ®Google Scholar
• Kaye KM , IzumiKM, KieffE. Epstein–Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci USA90(19), 9150–9154 (1993).
   PubMed Web of Science ®Google Scholar
• Ikeda O , SekineY, MizushimaAet al. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein–Barr virus-derived LMP1. FEBS Lett.583(10), 1567–1574 (2009).
   PubMed Web of Science ®Google Scholar
• Caldwell RG , WilsonJB, AndersonSJ, LongneckerR. Epstein–Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity9(3), 405–411 (1998).
   PubMed Web of Science ®Google Scholar
• Swanson-Mungerson M , BultemaR, LongneckerR. Epstein–Barr virus LMP2A imposes sensitivity to apoptosis. J. Gen. Virol.91(Pt 9), 2197–2202 (2010).
   PubMedGoogle Scholar
• Friborg J Jr. , KongW, HottigerMO, NabelGJ. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature402(6764), 889–894 (1999).
   PubMed Web of Science ®Google Scholar
• Cai QL , KnightJS, VermaSC, ZaldP, RobertsonES. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog.2(10), e116 (2006).
   PubMed Web of Science ®Google Scholar
• An J , SunY, SunR, RettigMB. Kaposi’s sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways. Oncogene22(22), 3371–3385 (2003).
   PubMed Web of Science ®Google Scholar
• Guasparri I , WuH, CesarmanE. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. EMBO Rep.7(1), 114–119 (2006).
   PubMed Web of Science ®Google Scholar
• Wang XW , ForresterK, YehH, FeitelsonMA, GuJR, HarrisCC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl Acad. Sci. USA91(6), 2230–2234 (1994).
   PubMed Web of Science ®Google Scholar
• Jung JK , AroraP, PaganoJS, JangKL. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res.67(12), 5771–5778 (2007).
   PubMed Web of Science ®Google Scholar
• Kuo TC , ChaoCC. Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. Biochem. Pharmacol.80(7), 1093–1102 (2010).
   PubMed Web of Science ®Google Scholar
• Khosravi R , MayaR, GottliebT, OrenM, ShilohY, ShkedyD. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl Acad. Sci. USA96(26), 14973–14977 (1999).
   PubMed Web of Science ®Google Scholar
• Tellinghuisen TL , RiceCM. Interaction between hepatitis C virus proteins and host cell factors. Curr. Opin. Microbiol.5(4), 419–427 (2002).
   PubMed Web of Science ®Google Scholar
• Lu L , WeiL, PengGet al. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology371(1), 61–70 (2008).
   PubMed Web of Science ®Google Scholar
• Gong GZ , JiangYF, HeY, LaiLY, ZhuYH, SuXS. HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding. World J. Gastroenterol.10(15), 2223–2227 (2004).
   PubMed Web of Science ®Google Scholar
• Schmitz U , TanSL. NS5A – from obscurity to new target for HCV therapy. Recent Pat Antiinfect. Drug Discov.3(2), 77–92 (2008).
   PubMedGoogle Scholar
• Kim YM , GeigerTR, EganDI, SharmaN, NyborgJK. The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription. Oncogene29(14), 2142–2152 (2010).
   PubMed Web of Science ®Google Scholar
• Gallo RC . History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene24(39), 5926–5930 (2005).
   PubMed Web of Science ®Google Scholar
• Buti L , SpoonerE, Van dV, RappuoliR, CovacciA, PloeghHL. Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc. Natl Acad. Sci. USA108(22), 9238–9243 (2011).
   PubMed Web of Science ®Google Scholar
• Nesic D , ButiL, LuX, StebbinsCE. Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2. Proc. Natl Acad. Sci. USA111(4), 1562–1567 (2014).
   PubMed Web of Science ®Google Scholar
• Saha A , KaulR, MurakamiM, RobertsonES. Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention. Cancer Biol. Ther.10(10), 961–978 (2010).
   PubMed Web of Science ®Google Scholar
• Scheffner M , WernessBA, HuibregtseJM, LevineAJ, HowleyPM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell63(6), 1129–1136 (1990).
   PubMed Web of Science ®Google Scholar
• Dyson N , HowleyPM, MungerK, HarlowE. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science243(4893), 934–937 (1989).
   PubMed Web of Science ®Google Scholar
• Hwang SG , LeeD, KimJ, SeoT, ChoeJ. Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner. J. Biol. Chem.277(4), 2923–2930 (2002).
   PubMed Web of Science ®Google Scholar
• Allen JE , MaizelsRM. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol.11(6), 375–388 (2011).
   PubMed Web of Science ®Google Scholar
• Tornesello M , AnnunziataC, BuonaguroL, LositoS, GreggiS, BuonaguroFM. TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix. J. Transl. Med.12(1), 255 (2014).
   PubMedGoogle Scholar
• Klingelhutz AJ , FosterSA, McDougallJK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature380(6569), 79–82 (1996).
   PubMed Web of Science ®Google Scholar
• Veldman T , HorikawaI, BarrettJC, SchlegelR. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol.75(9), 4467–4472 (2001).
   PubMed Web of Science ®Google Scholar
• Oh ST , KyoS, LaiminsLA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J. Virol.75(12), 5559–5566 (2001).
   PubMed Web of Science ®Google Scholar
• Veldman T , LiuX, YuanH, SchlegelR. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl Acad. Sci. USA100(14), 8211–8216 (2003).
   PubMed Web of Science ®Google Scholar
• Kim WY , SharplessNE. The regulation of INK4/ARF in cancer and aging. Cell127(2), 265–275 (2006).
   PubMed Web of Science ®Google Scholar
• Jarrard DF , SarkarS, ShiYet al. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res.59(12), 2957–2964 (1999).
   PubMed Web of Science ®Google Scholar
• Darbro BW . Mechanisms of human epithelial cell immortalization and p16NK4a induced telomere-independent sencescence [PhD thesis]. University of Iowa, Iowa City, IA, USA (2007). http://ir.uiowa.edu/etd/183.
   Google Scholar
• Liggett WH Jr , SidranskyD. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol.16(3), 1197–1206 (1998).
   PubMed Web of Science ®Google Scholar
• Sharpless NE . INK4a/ARF: a multifunctional tumor suppressor locus. Mutat. Res.576(1–2), 22–38 (2005).
   PubMed Web of Science ®Google Scholar
• Perez-Sayans M , Suarez-PenarandaJM, Padin-IruegasMEet al. The loss of p16 expression worsens the prognosis of OSCC. Appl. Immunohistochem. Mol. Morphol. (2015).
   PubMedGoogle Scholar
• Weinberger PM , YuZ, HafftyBGet al. Molecular classification identifies a subset of human papillomavirus – associated oropharyngeal cancers with favorable prognosis. J. Clin. Oncol.24(5), 736–747 (2006).
   PubMed Web of Science ®Google Scholar
• Tornesello ML , PerriF, BuonaguroL, IonnaF, BuonaguroFM, CaponigroF. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches. Cancer Lett.351(2), 198–205 (2014).
   PubMed Web of Science ®Google Scholar
• Kotake Y , CaoR, ViatourP, SageJ, ZhangY, XiongY. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev.21(1), 49–54 (2007).
   PubMed Web of Science ®Google Scholar
• Tornesello ML , BuonaguroL, Giorgi-RossiP, BuonaguroFM. Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed. Res. Int.2013, 519619 (2013).
   PubMed Web of Science ®Google Scholar
• Li J , MuscarellaP, JooSHet al. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A). Biochemistry44(40), 13246–13256 (2005).
   PubMed Web of Science ®Google Scholar
• Li J , PoiMJ, TsaiMD. Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry50(25), 5566–5582 (2011).
   PubMed Web of Science ®Google Scholar
• de Martel C , FerlayJ, FranceschiSet al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol.13(6), 607–615 (2012).
   PubMed Web of Science ®Google Scholar
• Tornesello ML , BuonaguroL, TatangeloF, BottiG, IzzoF, BuonaguroFM. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics102(2), 74–83 (2013).
   PubMed Web of Science ®Google Scholar
• Mesri EA , FeitelsonMA, MungerK. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host. Microbe15(3), 266–282 (2014).
   PubMed Web of Science ®Google Scholar
• Bolukbas C , BolukbasFF, HorozM, AslanM, CelikH, ErelO. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect. Dis.5, 95 (2005).
   PubMed Web of Science ®Google Scholar
• Fujita N , SugimotoR, MaNet al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J. Viral Hepat.15(7), 498–507 (2008).
   PubMed Web of Science ®Google Scholar
• Jaeschke H . Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J. Gastroenterol. Hepatol.26(Suppl.1), 173–179 (2011).
   PubMed Web of Science ®Google Scholar
• Lee YI , HwangJM, ImJHet al. Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J. Biol. Chem.279(15), 15460–15471 (2004).
   PubMed Web of Science ®Google Scholar
• Zemel R , IssacharA, Tur-KaspaR. The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma. Clin. Liver Dis.15(2), 261–26x (2011).
   PubMed Web of Science ®Google Scholar
• Hu L , ChenL, YangGet al. HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade. Mol. Cancer10, 43 (2011).
   PubMed Web of Science ®Google Scholar
• Sieghart W , LosertD, StrommerSet al. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J. Hepatol.44(1), 151–157 (2006).
   PubMed Web of Science ®Google Scholar
• Wang WL , LondonWT, LegaL, FeitelsonMA. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology14(1), 29–37 (1991).
   PubMed Web of Science ®Google Scholar
• Martin-Vilchez S , Lara-PezziE, Trapero-MaruganM, Moreno-OteroR, Sanz-CamenoP. The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection. Rev. Med. Virol.21(5), 315–329 (2011).
   PubMed Web of Science ®Google Scholar
• Jin YM , YunC, ParkC, WangHJ, ChoH. Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J. Viral Hepat.8(5), 322–330 (2001).
   PubMed Web of Science ®Google Scholar
• Gong G , WarisG, TanveerR, SiddiquiA. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl Acad. Sci. USA98(17), 9599–9604 (2001).
   PubMed Web of Science ®Google Scholar
• Okuda M , LiK, BeardMRet al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology122(2), 366–375 (2002).
   PubMed Web of Science ®Google Scholar
• Boudreau HE , EmersonSU, KorzeniowskaA, JendrysikMA, LetoTL. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J. Virol.83(24), 12934–12946 (2009).
   PubMed Web of Science ®Google Scholar
• de Mochel NS , SeronelloS, WangSHet al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology52(1), 47–59 (2010).
   PubMed Web of Science ®Google Scholar
• Santos CX , TanakaLY, WosniakJ, LaurindoFR. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox. Signal.11(10), 2409–2427 (2009).
   PubMed Web of Science ®Google Scholar
• Kumthip K , ChusriP, JilgNet al. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J. Virol.86(16), 8581–8591 (2012).
   PubMed Web of Science ®Google Scholar
• Rehermann B . Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest.119(7), 1745–1754 (2009).
   PubMed Web of Science ®Google Scholar
• Brechot C . Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology127(5 Suppl. 1), S56-S61 (2004).
   Web of Science ®Google Scholar
• Jeong SW , JangJY, ChungRT. Hepatitis C virus and hepatocarcinogenesis. Clin. Mol. Hepatol.18(4), 347–356 (2012).
   PubMedGoogle Scholar
• Ray RB , MeyerK, RayR. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology271(1), 197–204 (2000).
   PubMed Web of Science ®Google Scholar
• Peek RM Jr , CrabtreeJE. Helicobacter infection and gastric neoplasia. J. Pathol.208(2), 233–248 (2006).
   PubMed Web of Science ®Google Scholar
• Ernst PB , PeuraDA, CroweSE. The translation of Helicobacter pylori basic research to patient care. Gastroenterology130(1), 188–206 (2006).
   PubMed Web of Science ®Google Scholar
• Segal ED , ChaJ, LoJ, FalkowS, TompkinsLS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl Acad. Sci. USA96(25), 14559–14564 (1999).
   PubMed Web of Science ®Google Scholar
• Viala J , ChaputC, BonecaIGet al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol.5(11), 1166–1174 (2004).
   PubMed Web of Science ®Google Scholar
• Ding SZ , ZhengPY. Helicobacter pylori infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges. Gut Pathog.4(1), 18 (2012).
   PubMedGoogle Scholar
• Ding SZ , FischerW, Kaparakis-LiaskosMet al. Helicobacter pylori-induced histone modification, associated gene expression in gastric epithelial cells, and its implication in pathogenesis. PLoS ONE5(4), e9875 (2010).
   PubMedGoogle Scholar
• Backert S , NaumannM. What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol.18(11), 479–486 (2010).
   PubMed Web of Science ®Google Scholar
• Lee IO , KimJH, ChoiYJet al. Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J. Biol. Chem.285(21), 16042–16050 (2010).
   PubMed Web of Science ®Google Scholar
• Jang BG , KimWH. Molecular pathology of gastric carcinoma. Pathobiology78(6), 302–310 (2011).
   PubMed Web of Science ®Google Scholar
• O’Gorman A , ColleranA, RyanA, MannJ, EganLJ. Regulation of NF-kappaB responses by epigenetic suppression of IkappaBalpha expression in HCT116 intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol.299(1), G96–G105 (2010).
   PubMed Web of Science ®Google Scholar
• Ohnishi N , YuasaH, TanakaSet al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl Acad. Sci. USA105(3), 1003–1008 (2008).
   PubMed Web of Science ®Google Scholar
• Hayashi D , TamuraA, TanakaHet al. Deficiency of claudin-18 causes paracellular H+ leakage, up-regulation of interleukin-1beta, and atrophic gastritis in mice. Gastroenterology142(2), 292–304 (2012).
   PubMed Web of Science ®Google Scholar
• Marusawa H , ChibaT. Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr. Opin. Immunol.22(4), 442–447 (2010).
   PubMed Web of Science ®Google Scholar
• Huang FY , ChanAO, RashidA, WongDK, ChoCH, YuenMF. Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1beta activation of nitric oxide production in gastric cancer cells. Cancer118(20), 4969–4980 (2012).
   PubMed Web of Science ®Google Scholar
• Leung SY , YuenST, ChungLP, ChuKM, ChanAS, HoJC. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res.59(1), 159–164 (1999).
   PubMed Web of Science ®Google Scholar
• Deng N , GohLK, WangHet al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut61(5), 673–684 (2012).
   PubMed Web of Science ®Google Scholar
• Olivier M , HollsteinM, HainautP. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol.2(1), a001008 (2010).
   PubMed Web of Science ®Google Scholar
• Murakami K , FujiokaT, OkimotoTet al. Analysis of p53 gene mutations in Helicobacter pylori-associated gastritis mucosa in endoscopic biopsy specimens. Scand. J. Gastroenterol.34(5), 474–477 (1999).
   PubMed Web of Science ®Google Scholar
• Piazzi G , FiniL, SelgradMet al. Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget.2(12), 1291–1301 (2011).
   PubMedGoogle Scholar
• Tomita H , TakaishiS, MenheniottTRet al. Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology140(3), 879–891 (2011).
   PubMed Web of Science ®Google Scholar
• Amieva MR , VogelmannR, CovacciA, TompkinsLS, NelsonWJ, FalkowS. Disruption of the epithelial apical–junctional complex by Helicobacter pylori CagA. Science300(5624), 1430–1434 (2003).
   PubMed Web of Science ®Google Scholar
• Saito Y , Murata-KamiyaN, HirayamaT, OhbaY, HatakeyamaM. Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. J. Exp. Med.207(10), 2157–2174 (2010).
   PubMed Web of Science ®Google Scholar
• Bagnoli F , ButiL, TompkinsL, CovacciA, AmievaMR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl Acad. Sci. USA102(45), 16339–16344 (2005).
   PubMed Web of Science ®Google Scholar
• Bessede E , StaedelC, cuna AmadorLAet al. Helicobacter pylori generates cells with cancer stem cell properties via epithelial–mesenchymal transition-like changes. Oncogene33(32), 4123–4131 (2014).
   PubMed Web of Science ®Google Scholar
• Serrano B , AlemanyL, TousSet al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect. Agent Cancer7(1), 38 (2012).
   PubMed Web of Science ®Google Scholar
• Buonaguro F , TorneselloM, BuonaguroL. The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens. J. Transl. Med.13(1), 33 (2015).
   PubMedGoogle Scholar
• Kowdley KV , GordonSC, ReddyKRet al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N. Engl. J. Med.370(20), 1879–1888 (2014).
   PubMed Web of Science ®Google Scholar
• Malfertheiner P , MegraudF, O’MorainCAet al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut61(5), 646–664 (2012).
   PubMed Web of Science ®Google Scholar
• Campistol JM , SchenaFP. Kaposi’s sarcoma in renal transplant recipients – the impact of proliferation signal inhibitors. Nephrol. Dial. Transplant.22Suppl 1, i17–i22 (2007).
   PubMedGoogle Scholar
• Calistri E , TiribelliM, BattistaMet al. Epstein–Barr virus reactivation in a patient treated with anti-thymocyte globulin for severe aplastic anemia. Am. J. Hematol.81(5), 355–357 (2006).
   PubMed Web of Science ®Google Scholar